TEM Tempus AI, Inc.

Overview and Growth

Fiscal 2025 results for Tempus AI, Inc. combined $1.27B of revenue with net loss of $245.03M and an operating cash outflow of $218.09M. At $1.27B, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Revenue was 83.4% above fiscal 2024 revenue of $693.40M, marking a year-over-year increase. Diluted earnings per share were -$1.41, translating the period’s attributable earnings into the amount reported for each diluted share. Diluted shares averaged 174.26K; this is the reported share base over which the company’s diluted per-share earnings were spread. The diluted share count was 45.4% higher than fiscal 2024, when diluted shares averaged 119.85K, adding context to the EPS comparison. At period end, total assets were $2.27B, framing the scale of the company’s operating and financing commitments. Revenue equaled 0.56x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Operations produced a $252.87M operating loss before non-operating and tax effects. The operating loss equaled 19.9% of revenue, showing the scale of the operating deficit relative to sales. After all below-operating-line items, the company recorded a net loss of $245.03M for the fiscal year. Measured against revenue, the bottom-line deficit represented 19.3% after all recognized items. EBITDA was negative $220.82M, showing a deficit before interest, taxes, depreciation, and amortization. An income-tax benefit of $51.68M improved the final result relative to pretax income or loss. The loss-to-equity relationship was 49.9%, placing the bottom-line deficit against shareholder capital. The loss-to-assets relationship was 10.8%, placing the bottom-line deficit against the company’s resource base. The net loss narrowed to $245.03M from $705.81M in fiscal 2024.

Liquidity and Capital Structure

At period end, the $2.27B asset base was financed through $1.78B of liabilities and $491.33M of equity. At period end, current assets of $1.17B compared with current liabilities of $372.39M, defining the company’s short-term resource position. At 3.13x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Reported cash and equivalents were $604.79M, separating immediately recognizable cash resources from the rest of the current-asset base. Cash and equivalents represented 162.4% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Book equity represented 21.6% of total assets, quantifying the balance-sheet share supported by shareholder capital. The liabilities-to-assets relationship was 78.4%, placing reported obligations against the full positive asset balance. The cash-to-assets relationship was 26.6%, comparing reported cash and equivalents with the full positive asset balance. Total assets were 145.6% higher than fiscal 2024 assets of $926.12M, measuring the company’s own balance-sheet change. Book equity was 772.1% higher than fiscal 2024 equity of $56.34M, showing how shareholder capital changed year over year. Compared with $340.95M in fiscal 2024, the current cash balance moved 77.4% and finished higher.

Cash Flow and Earnings Quality

Cash flow from operations was an outflow of $218.09M, showing that operations absorbed cash during the period. Capital expenditures used $21.05M in addition to the operating cash outflow, increasing the total cash consumed by operations and investment during the period. Operating cash flow and capital spending combined to leave a $239.14M cash deficit after capital spending. The free-cash-flow deficit equaled 18.8% of revenue, showing the post-investment cash shortfall relative to sales. Relative to total assets, the post-investment cash deficit measured 10.5%. Compared with a $189.04M operating cash outflow in fiscal 2024, the current outflow increased to $218.09M.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.